Improved health-related quality of life and left venticular hypertrophy among dialysis patients treated with parathyroidectomy

Journal of Nephrology

Volumn 16, Issue 6, 2003, Pages 878-885

  Chow, Kai Ming ^a   Szeto, Cheuk Chun ^a   Kum, Leo Chi Chiu ^a   Kwan, Bonnie Ching Ha ^a   Fung, Terence Ming Kit ^a   Wong, Teresa Yuk Hwa ^a   Leung, Chi Bon ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Dialysis; Health related quality of life; KDQOL SF ; Left venticular hypetrophy; Parathyroidectomy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMOTIONALITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; KIDNEY FAILURE; MALE; PAIN ASSESSMENT; PARATHYROIDECTOMY; PATIENT ATTITUDE; PERITONEAL DIALYSIS; PHYSICAL CAPACITY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME; CHRONIC KIDNEY FAILURE; HEALTH STATUS; MIDDLE AGED; PATHOPHYSIOLOGY; SECONDARY HYPERPARATHYROIDISM;

FEMALE; HEALTH STATUS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROIDECTOMY; QUALITY OF LIFE;

EID: 1642446087     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Burney RE, Jones KR, Peterson M, Christy B, Thompson NW. Surgical correction of primary hyperparathyroidism improves quality of life. Surgery 1998; 124: 987-1
2. Talpos GB, Bone HG III, Kleerekoper M, Phillips ER, Alam M, Honasoge M, Divine GW, Rao DS. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 2000; 128: 1013-20
3. Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J, Krzywda B. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 2002; 26: 942-9
4. Sheldon DG, Lee FT, Neil NJ, Ryan JA Jr. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 2002; 137: 1022-8
5. Rostand SG, Drüeke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999; 56: 383-92
6. Billa V, Zhong A, Bargman J, Vas S, Wong PY, Oreopoulos DG. High prevalence of hyperparathyroidism among peritoneal dialysis patients: a review of 176 patients. Perit Dial Int 2000; 20: 315-21
7. Blakewell AB, Higgins RM, Edmunds ME. Quality of life in peritoneal dialysis patients: decline over time and association with clinical outcomes. Kidney Int 2002; 61: 239-48
8. Ljutić D, Cameron JS, Ogg CS, Turner C, Hicks JA, Owen WJ. Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure. QJ Med 1994; 87: 685-92
9. Chou FF, Lee CH, Chen JB, Hsu KT, Sheen-Chen SM. Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg 2002; 137: 341-4
10. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the Kidney Disease Quality of Life (KDQOLTM) instrument. Qual Life Res 1994; 3: 329-38
11. Hays RD, Kallich JD, Mapes DL, Coons SJ, Amin N, Carter WB. Kidney Disease Quality of Life Short Form (KDQOL-SFTM), Version 1.3: A manual for use and scoring. Santa Monica, CA: RAND 1995
12. Korevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT, for the NECOSAD-Study Group. Validation of the KDQOL-SFTM: a dialysis-targeted health measure. Qual Life Res 2002; 11: 437-47
13. Thumboo J, Fong KY, Chan SP, Machin D, Feng PH, Thio ST, Boey ML. The equivalence of English and Chinese SF-36 versions in bilingual Singapore Chinese. Qual Life Res 2002; 11: 495-503
14. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center 1993.
15. Gardin JM, Adams DB, Douglas PS, Feigenbaum H, Forst DH, Fraser AG, Grayburn PA, Katz AS, Keller AM, Kerber RE, Khandheria BK, Klein AL, Lang RM, Pierard LA, Quinones MA, Schnittger I. Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr 2002; 15: 275-90
16. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-84
17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-8
18. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879-84
19. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 2001; 12: 2797-806
20. Parkerson GR Jr, Gutman RA. Health-related quality of life predictors of survival and hospital utilization. Healthcare Financ Rev 2000; 21: 171-84
21. Valderrábano F, Jofre R, López-Gómez JM. Quality of life in end-stage renal disease patients. Am J Kidney Dis 2001; 38: 443-64
22. Merkus MP, Jager KJ, Dekker FW, De Haan RJ, Boeschoten EW, Krediet RT for the NECOSAD Study Group. Quality of life over time in dialysis: The Netherlands cooperative study on the adequacy of dialysis. Kidney Int 1999; 56: 720-8
23. Hampers CL, Katz AL, Wilson RE, Merril JP. Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med 1968; 279: 695-7
24. Massry SG, Popvtzer MM, Corburn JW, Makoff DL, Maxwell MH, Kleeman CR. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia: disappearance of itching after subtotal parathyroidectomy. N Engl J Med 1968; 279: 697-700
25. Carmichael AJ, McHugh M, Martin AM. Serological markers of renal itch in patients receiving long term haemodialysis. Br Med J 1988; 296: 1575
26. Cho YL, Liu HN, Huang TP, Tarng DC. Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol 1997; 36: 538-43
27. Chou FF, Ho JC, Huang SC, Sheen-Chen SM. A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 2000; 190: 65-70
28. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus - new perspectives and insights from recent trials. Nephrol Dial Transplant 2002; 17: 1558-63
29. Levitt MD, Vivian AB, Saker BM. Parathyroidectomy in chronic renal failure. Aust N Z J Surg 1986; 56: 233-9
30. Ståhle-Bäckdahl M, Hägermark O, Lins LE. Pruritus in patients on maintenance hemodialysis. Acta Med Scand 1988; 224: 55-60
31. Schlüter KD, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 1998; 37: 34-41
32. Massry SG. Uremic toxicity - parathyroid hormone as a uremic toxin. In: Massry SG, Glassock RJ. Eds. Massry & Glassock's Textbook of Nephrology (4th eds). Philadelphia: Lippincott Williams & Wilkins 2001: 1238-9
33. London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 2002; 17 (suppl 1): S29-36
34. Bogin E, Massry SG, Harary I. Effect of parathyroid hormone on heart cells. J Clin Invest 1981; 67: 1215-27
35. Katoh T, Klein KL, Kaplan RA, Sanborn WG, Kurokawa K. Parathyroid hormone has a positive inotropic action in the rat. Endocrinology 1981; 109: 2252-4
36. Schlüter KD, Piper HM. Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Physiol 1992; 261: H1945-50
37. Amann K, Ritz E, Wiest G, Klaus G, Mall G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994; 4: 1814-9.
38. Palmieri GM, Nutting DF, Bhattacharya SK, Bertorini TE, Williams JC. Parathyroid ablation in dystrophic hamsters: effects on Ca content and histology of heart, diaphragm, and rectus femoris. J Clin Invest 1981; 68: 646-54
39. Amann K, Ritz E. Cardiac disease in chronic uremia: pathophysiology. Adv Ren Replace Ther 1997; 4: 212-24
40. Drüeke T, Fauchet M, Fleury J, Lesourd P, Toure Y, Le Pailleur C, de Vernejoul P, Crosnier J. Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet 1980; 1: 112-14
41. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993; 95: 197-202
42. Sato S, Ohta M, Kawaguchi Y, Okada H, Ono M, Saito H, Utsunomiya M, Tamura T, Sugimoto K, Takamizawa S, Tanaka H, Shigematsu T, Tojo K, Sakai O. Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab 1995; 21: 67-71
43. Hara S, Ubara Y, Arizono K, Ikeguchi H, Katori H, Yamada A, Ogura Y, Murata H, Mimura N. Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients. Miner Electrolyte Metab 1995; 21: 72-6
44. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33: 733-81
45. Dominiczak AN, Lyall F, Morton JJ, Dargie HJ, Boyle IT, Tune TT, Murray G, Semple PF. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin Sci (Lond) 1990; 78: 127-32
46. Gafter U, Battler A, Eldar M, Zevin D, Neufeld HN, Levi J. Effect of hyperparathyroidism on cardiac function in patients with end-stage renal disease. Nephron 1985; 41: 30-3
47. Fellner SK, Lang RM, Neumann A, Bushinsky DA, Borow KM. Parathyroid hormone and myocardial performance in dialysis patients. Am J Kidney Dis 1991; 18: 320-5
48. Nilsson IL, Åberg J, Rastad J, Lind L. Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism - effects of parathyroidectomy. Surgery 2000; 128: 895-902
49. Nappi S, Saha H, Virtanen V, Limnell V, Sand J, Salmi J, Pasternack A. Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. Cardiology 2000; 93: 229-33